Edinburgh Research Explorer

PGE2 production at sites of tissue injury promotes an anti-inflammatory neutrophil phenotype and determines the outcome of inflammation resolution in vivo

Research output: Contribution to journalArticlepeer-review

  • Catherine A. Loynes
  • Jou A . Lee
  • Anne L. Robertson
  • Michael J. G. Steel
  • Felix Ellett
  • Yi Feng
  • Bruce D. Levy
  • Moira K. B. Whyte
  • Stephen A. Renshaw

Related Edinburgh Organisations

Open Access permissions



  • Download as Adobe PDF

    Rights statement: Copyright © 2018 The Authors, some rights reserved; exclusive licensee American Association for the Advancement of Science. No claim to original U.S. Government Works. Distributed under a Creative Commons Attribution License 4.0 (CC BY).

    Final published version, 3.15 MB, PDF document

    Licence: Creative Commons: Attribution (CC-BY)

Original languageEnglish
Article numbereaar8320
Number of pages14
JournalScience Advances
Issue number9
Publication statusPublished - 5 Sep 2018


Neutrophils are the first immune cells recruited to a site of injury or infection, where they perform many functions. Having completed their role, neutrophils must be removed from the inflammatory site—either by apoptosis and efferocytosis or by reverse migration away from the wound—for restoration of normal tissue homeostasis. Disruption of these tightly controlled physiological processes of neutrophil removal can lead to a range of inflammatory diseases. We used an in vivo zebrafish model to understand the role of lipid mediator production in neutrophil removal. Following tailfin amputation in the absence of macrophages, neutrophillic inflammation does not resolve, due to loss of macrophage-dependent handling of eicosanoid prostaglandin E2 (PGE2) that drives neutrophil removal via promotion of reverse migration. Knockdown of endogenous PGE synthase gene reveals PGE2 as essential for neutrophil inflammation resolution. Furthermore, PGE2 is able to signal through EP4 receptors during injury, causing an increase in Alox12 production and switching toward anti-inflammatory eicosanoid signaling. Our data confirm regulation of neutrophil migration by PGE2 and LXA4 (lipoxin A4) in an in vivo model of inflammation resolution. This pathway may contain therapeutic targets for driving inflammation resolution in chronic inflammatory disease.

Download statistics

No data available

ID: 70467671